UniSuper Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$132M Buy
1,099,802
+241
+0% +$27.8K 0.87% 20
2025
Q4
$116M Buy
1,099,561
+12,438
+1% +$1.17M 0.69% 24
2025
Q3
$91.2M Buy
1,087,123
+160,345
+17% +$13.2M 0.56% 32
2025
Q2
$73.4M Buy
926,778
+32,269
+4% +$2.57M 0.49% 37
2025
Q1
$80.3M Buy
894,509
+9,800
+1% +$915K 0.6% 27
2024
Q4
$88M Sell
884,709
-20,007
-2% -$2.06M 0.63% 23
2024
Q3
$103M Sell
904,716
-381,116
-30% -$45.3M 0.77% 21
2024
Q2
$159M Buy
1,285,832
+447,769
+53% +$57.7M 1.32% 13
2024
Q1
$111M Buy
838,063
+19,831
+2% +$2.44M 1.06% 21
2023
Q4
$89.2M Sell
818,232
-18,989
-2% -$1.97M 0.99% 23
2023
Q3
$86.2M Buy
837,221
+55,376
+7% +$5.97M 1.06% 21
2023
Q2
$90.2M Buy
+781,845
New +$88.8M 1.02% 21

Other funds holding MRK

UniSuper Management's MRK Position: Q1 2026 in Review

UniSuper Management increased its Merck (MRK) stake by 0.02% in Q1 2026, buying an estimated $27.8K and bringing the position to 1,099,802 shares worth $132M. The position accounts for 0.87% of the portfolio, ranked #20.

UniSuper Management first reported a position in MRK in Q2 2023 and has held it in 12 quarters since. The position peaked at $159M in Q2 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • UniSuper Management held 1,099,802 shares of Merck worth $132M as of Q1 2026.
  • UniSuper Management bought 241 Merck shares in Q1 2026, an estimated $27.8K.
  • Merck made up 0.87% of UniSuper Management's portfolio in Q1 2026, its #20 holding.
  • UniSuper Management first reported a position in Merck in Q2 2023 and has held it in 12 quarters since.
  • UniSuper Management's Merck position peaked at $159M in Q2 2024.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on UniSuper Management's 13F filing for Q1 2026, filed 11 May 2026.